Monday - December 23, 2024
Ropes & Gray: Nona Biosciences Announces Global License, Option Agreement With AstraZeneca
May 24, 2024
BOSTON, Massachusetts, May 24 -- Ropes and Gray, a law firm, issued the following news:

Ropes & Gray advised Nona Biosciences in a license agreement with AstraZeneca for preclinical monoclonal antibodies that will be used to develop targeted oncology therapies using Nona's antibody discovery platform. The transaction was announced on May 22.

Under the agreement, Nona will receive $19 million upon completion of the transaction. Nona is eligible to receive an addition . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products